Quotient Limited Provides Update on CE Marking Progress of the MosaiQ™ Expanded Immunohematology Microarray
October 01, 2021 06:00 ET
|
Quotient Limited
JERSEY, Channel Islands, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the launch of the review process of...
Quotient Limited Announces Christian Albrich as Chief People Officer
September 01, 2021 08:21 ET
|
Quotient Limited
JERSEY, Channel Islands, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland,...
Quotient Limited Announces Departure of Chief Commercial Officer, Jeremy Stackawitz
August 11, 2021 07:45 ET
|
Quotient Limited
JERSEY, Channel Islands, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), announced that Jeremy Stackawitz has notified the...
Quotient Limited Provides First Quarter Fiscal 2022 Results and Business Update
August 05, 2021 06:30 ET
|
Quotient Limited
MosaiQ™ Solution Transfusion Dx: Latest data confirms performance of MosaiQ Expanded IH; Expanded SDS microarray demonstrates excellent performanceCommercial Execution: Significant progress made with...
Quotient Limited Announces Equity Awards
August 02, 2021 16:30 ET
|
Quotient Limited
JERSEY, Channel Islands, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the grant of equity awards to Dr....
Quotient Limited to Report First Quarter Fiscal Year 2022 Financial Results and Host Conference Call
July 29, 2021 08:30 ET
|
Quotient Limited
JERSEY, Channel Islands, July 29, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal first quarter...
Quotient Limited Announces Departure of Chief Financial Officer, Peter Buhler
July 02, 2021 16:30 ET
|
Quotient Limited
JERSEY, Channel Islands, July 02, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), announced that Peter Buhler has notified the Company...
Quotient Limited Provides Fourth Quarter and Full Year Fiscal 2021 Results and provides Business Update
June 01, 2021 06:30 ET
|
Quotient Limited
New Chief Technology Officer (CTO) appointed to accelerate innovation and further strengthen organizational capabilitiesContinuing robust progress in advancing the MosaiQ transfusion diagnostics...
Quotient Limited to Participate in Upcoming Investor Conferences
May 31, 2021 08:00 ET
|
Quotient Limited
JERSEY, Channel Islands, May 31, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the management team will participate in two upcoming...
Quotient Limited to Report Fiscal Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call
May 25, 2021 08:30 ET
|
Quotient Limited
JERSEY, Channel Islands, May 25, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal fourth quarter...